Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

8 Feb 2012 07:00

RNS Number : 9954W
Imaginatik PLC
08 February 2012
 

8 February 2012

 

 

Imaginatik Plc

("Imaginatik" or "the Company")

Issue of Equity

 

Imaginatik plc (AIM:IMTK), a leading provider of enterprise innovation services including a range of technology products and consultancy, is pleased to announce that following demand from certain existing and new investors, 85,505,352 new ordinary shares of 0.0625p each in the Company ("Subscription Shares") have been subscribed for at a price per share of 0.3 pence (the "Subscription Price"), to raise £256,516 before expenses. The Company intends that the net proceeds of the issue will be used for working capital purposes.

 

Application has been made for the new Shares to be admitted to trading on AIM, and dealings in the Subscription Shares are expected to commence at 8.00 a.m. on 13 February 2012 ("Admission"), following which the Company will have 513,032,110 Ordinary Shares in issue. This figure may be used by shareholders, from Admission, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

The Directors named below have subscribed for Subscription Shares as set out below at the Subscription Price:

 

 

Name of Director

Number of Subscription Shares

 

conditionally subscribed for

Simon Charles

3,284,270

Matt Cooper

22,327,693

David Gammon

7,442,564

Brian Hays

954,175

Shawn Taylor

893,108

 

Each Directors' interests in Ordinary Shares in the Company is accordingly as follows:

 

Name of Director

Ordinary Shares held legally or beneficially

Options to subscribe for new Ordinary Shares

Agreement to subscribe for Subscription Shares

Aggregate interests in Ordinary Shares at Admission

Aggregate percentage of issued share capital at Admission

Simon Charles

8,702,501

-

3,284,270

11,986,771

2.34

Matt Cooper

32,811,922

3,125,000

22,327,693

58,264,615

11.36

David Gammon

5,000,000

-

7,442,564

12,442,564

2.43

Nick Goss

-

-

-

-

-

Brian Hays

6,000,000

-

954,175

6,954,175

1.36

Luis Solis

-

4,000,000

-

4,000,000

0.78

Shawn Taylor

5,712,192

6,200,000

893,108

12,805,300

2.50

 

 

The interests of Mr Gammon set out above in ordinary shares include those of his wife, Sarah Gammon.

 

The aggregate subscription by the Directors (the "Directors' Participations") constitutes a related party transaction for the purposes of the AIM Rules. Luis Solis, the Director who is deemed to be independent for the purposes of this participation in the subscription, considers, having consulted with Northland Capital Partners Limited as the Company's nominated adviser, that the terms of the Directors' Participations are fair and reasonable insofar as Shareholders are concerned.

Executive Chairman of Imaginatik, Matt Cooper, commented, "We have taken significant strides forward in recent months, strengthening our team, investing in our technology products and services and securing some of the world's largest businesses as customers. We are delighted that this progress has resulted in increased interest from employees and investors to fund the Company. Imaginatik is in a strong position, with a good sales pipeline and a motivated team and we continue to be focused on delivering the positive results our shareholders deserve."

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Executive Chairman / Shawn Taylor, CFO

 

 

 

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

 

 

 

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

 

 

About Imaginatik

 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEAFAXESEAEAF
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.